3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Lymphoma, Large B-Cell, Diffuse
7
Lymphoma, B-Cell
6
Recurrence
4
Lymphoma, Mantle-Cell
3
Lymphoma
3
Burkitt Lymphoma
3
Neoplasms
2
Lymphoma, Non-Hodgkin
2
Leukemia, B-Cell
2
Sarcoma, Ewing
1
Rhabdomyosarcoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Osteosarcoma
1
Neuroblastoma
1
Multiple Myeloma
1
Lymphoma, T-Cell
1
Leukemia, Myeloid, Acute
1
Leukemia
1
Central Nervous System Neoplasms
1
Brain Neoplasms
1
Interventions
Cyclophosphamide
17
Etoposide
10
fludarabine
9
Whole-Body Irradiation
9
Brentuximab Vedotin
9
Melphalan
8
fludarabine phosphate
7
Vincristine
7
Mycophenolic Acid
7
Gemcitabine
7
Doxorubicin
7
Prednisone
6
Granulocyte Colony-Stimulating Factor
6
Busulfan
6
Vorinostat
5
Rituximab
5
Peripheral Blood Stem Cell Transplantation
5
Lenalidomide
5
Filgrastim
5
Cytarabine
5
Bortezomib
5
romidepsin
4
pembrolizumab
4
duvelisib
4
Tacrolimus
4
Stem Cell Transplantation
4
Carmustine
4
etoposide phosphate
3
Sirolimus
3
Dexamethasone
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Lymphoma, T-Cell
×
Immunotherapy, Adoptive
×
Clear all
NCT01685606
2022-03-04
273
Brown University
Phase 2
Terminated
6 enrolled
7 charts